Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Diabetes Prevention Post-Gestational Diabetes
NCT04615351Phase 3Unknown
- Sponsor
- Women & Infants Hospital
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Women & Infants Hospital. Primary endpoint: Incidence of Prediabetes or Diabetes at 1 year. Status: unknown.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04615351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04615351.